Statin Therapy in Heart Failure: Potential Mechanisms of Benefit

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Heart Failure, Congestive
Interventions
DRUG

atorvastatin

atorvastatin 10mg PO QD

DRUG

placebo

matched placebo Qd x 3 months

Trial Locations (1)

90095

Ahmanson-UCLA Cardiomyopathy Center, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, Los Angeles

OTHER